SunTech to use Masimo tech in new vital signs device
SunTech Medical said today it will work with Masimo (NSDQ:MASI) to integrate its SET pulse oximetry tech into SunTech’s CT40 next-gen spot-check vital signs device. Masimo’s SET technology is designed...
View ArticleCentinel Spine wins Australian clearance for Stalif L implant
Centinel Spine said yesterday it won Australian Therapeutic Goods Administration clearance for its Stalif L no-profile lateral lumbar integrated interbody system. Centinel Spine touts the Stalif L as...
View ArticleBrazilian medical device regulators moving to electronic submission system
By Stewart Eisenhart, Emergo Group ANVISA, Brazil’s medical device marker regulator, has announced plans to begin accepting electronic submissions of registration documents from manufacturers. The new...
View ArticleJohnson & Johnson wants Pinnacle bellwethers stayed after $500m loss
A Johnson & Johnson (NYSE:JNJ) subsidiary wants a federal appeals court to hit the pause button in the multi-district litigation over its Pinnacle metal-on-metal hip implant to give it enough time...
View ArticleArkis BioSciences lands $3m Series A for neurosurgery tools
Arkis BioSciences said today that it raised a $3.4 million Series A round for its line of neurosurgical tools, led by Innova Memphis. Angel Capital Group, the Lighthouse Fund and private investors also...
View ArticleLife Spine’s foot & ankle division, Centric Medical, wins FDA nod for...
Centric Medical, the foot & ankle division of Life Spine, said yesterday that it won 510(k) clearance from the FDA for its subtalar arthroereisis implant for treating flatfoot deformities. The...
View ArticleU.K. launches study of Dune Medical’s MarginProbe breast cancer device
Dune Medical Devices said this week that the U.K.’s National Health Service is launching a study of its MarginProbe device, which is designed to spot cancerous cells on the margins of breast tumors....
View ArticleInVivo Therapeutics touts case study in 1st spine scaffold implant
InVivo Therapeutics (NSDQ:NVIV) this week touted a case study of the 1st implantation of its spinal scaffold, a bioresorbable device designed to help treat traumatic spinal cord injuries. The study,...
View ArticleSonoSim, GE Healthcare re-up ultrasound training deal
Ultrasound education focused SonoSim said this week it is extending a collaboration with GE Healthcare (NYSE:GE) to cover ultrasound training and education for GE’s women’s health and urology...
View ArticleFresenius touts 10-year dialysis mortality reduction
Fresenius (NYSE:FMS) this week released data from an internal annual medical report, touting a 27% reduction in mortality and 22% reduction in hospitalizations amongst its permanent dialysis patients...
View ArticleMassDevice.com +5 | The top 5 medtech stories for June 24, 2016
Say hello to MassDevice +5, a bite-sized view of the top five medtech stories of the day. This feature of MassDevice.com’s coverage highlights our 5 biggest and most influential stories from the day’s...
View ArticleMayo Clinic study yields potential stem cell treatment for bronchopleural...
A new study from the Mayo Clinic has yielded a possible solution for treating bronchopleural fistulas using stem cells harvested from the patient’s abdominal tissue seeded into bioabsorbable meshes....
View ArticleHelius touts 6-patient study of advanced MS cases
Helius Medical Technologies this week released the result of a 6-patient pilot study of its PoNS therapy used to treat the advanced symptoms of multiple sclerosis, touting improvements in physical,...
View ArticleFDA: A great place for science…and for scientists on the new frontier of...
By: Robert M. Califf, M.D. As FDA Commissioner, I’m proud of our agency’s extraordinary commitment to using the best available science to support our mission to protect and promote the health of the...
View ArticleMedtronic to put up $1.1B for HeartWare
Medtronic (NYSE:MDT) said today that it agreed to put up $1.1 billion for implantable cardiac pump maker HeartWare International (NSDQ:HTWR). The $58-per-share deal, which represents a 93.4% premium...
View ArticleShareholders sue TransEnterix over shelved SurgiBot
TransEnterix (NYSE:TRXC) said today that it’s being sued by a pair of shareholders over its failure to win FDA clearance for the SurgiBot robot-assisted surgery device. Research Triangle Park,...
View ArticleZimmer Biomet clears U.S. anti-trust waiting period on LDR Holding acquisition
Zimmer Biomet (NYSE:ZBH) said today that its pending, $1 billion acquisition of LDR Holding (NSDQ:LDRH) cleared the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act. The...
View ArticleMedtronic, Cochlear get in on $51m Earlens round
Earlens said today that it raised a funding round worth $51 million for the light-driven hearing aid it developed, pulling down $34 million in cash and another $17 million in a bridge financing...
View ArticleCRO Medpace registers $150m IPO
Contract research organization Medpace last week registered for a $150 million initial public offering it plans to use to pay down some of its debt. Private equity shop Cinven paid CCMP Capital...
View ArticleAccuray wins FDA nod for Radixact image-guided radiotherapy
Accuray (NSDQ:ARAY) said today it won FDA 510(k) clearance for its Radixact treatment delivery platform designed for image-guided radiotherapy treatments designed for cancer patients. The company said...
View Article